Onderneming Citius Pharmaceuticals, Inc.
Aandelen
CTXR
US17322U2078
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,7263 USD | -2,68% | +1,37% | -3,99% |
Vakgebied
Aantal werknemers: 22
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01-07-13 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 27-11-17 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-22 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 14-07-20 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-16 |
Gary Talarico
COO | Chief Operating Officer | 69 | 01-03-16 |
Myron Holubiak
BRD | Director/Board Member | 77 | 01-10-15 |
Ilanit Allen
IRC | Investor Relations Contact | - | 17-05-21 |
General Counsel | - | 10-02-22 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 01-10-15 |
Dennis McGrath
BRD | Director/Board Member | 67 | 07-02-23 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01-07-13 |
Carol Webb
BRD | Director/Board Member | 78 | 01-03-16 |
Suren Dutia
BRD | Director/Board Member | 82 | 01-10-15 |
Eugene Holuka
BRD | Director/Board Member | 65 | 01-06-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 180 395 150 | 168 087 211 ( 93,18 %) | 0 | 93,18 % |
Bedrijfsgegevens
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,99% | 131 mln. | |
+0,67% | 42,4 mld. | |
+46,11% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
+16,03% | 11,32 mld. | |
-4,80% | 11,55 mld. |
- Beurs
- Aandelen
- Koers CTXR
- Onderneming Citius Pharmaceuticals, Inc.